These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 35717194)

  • 1. Thirty-year clinical outcomes after haematopoietic stem cell transplantation in neuronopathic Gaucher disease.
    Donald A; Björkvall CK; Vellodi A; ; Cox TM; Hughes D; Jones SA; Wynn R; Machaczka M
    Orphanet J Rare Dis; 2022 Jun; 17(1):234. PubMed ID: 35717194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation or enzyme replacement therapy in Gaucher disease type 3.
    Høj A; Ørngreen MC; Naume MM; Lund AM
    Mol Genet Metab; 2024 Aug; 142(4):108515. PubMed ID: 38909587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy in a patient with chronic neuronopathic Gaucher disease: a case report.
    Ceravolo F; Grisolia M; Sestito S; Falvo F; Moricca MT; Concolino D
    J Med Case Rep; 2017 Jan; 11(1):19. PubMed ID: 28103924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicogenetic Profile, Treatment Modalities, and Mortality Predictors of Gaucher Disease: A 15-Year Retrospective Study.
    Barney AM; Danda S; Abraham A; Fouzia NA; Gowdra A; Abraham SSC; Sony M; Das S; Korula S; Mathai S; Simon A; Kumar S
    Public Health Genomics; 2021; 24(3-4):139-148. PubMed ID: 33823526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme replacement and substrate reduction therapy for Gaucher disease.
    Shemesh E; Deroma L; Bembi B; Deegan P; Hollak C; Weinreb NJ; Cox TM
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010324. PubMed ID: 25812601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long term effects of enzyme replacement therapy in an Italian cohort of type 3 Gaucher patients.
    Sechi A; Deroma L; Dardis A; Ciana G; Bertin N; Concolino D; Linari S; Perria C; Bembi B
    Mol Genet Metab; 2014 Nov; 113(3):213-8. PubMed ID: 25127542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive and long-term outcomes of enzyme replacement therapy followed by stem cell transplantation in children with Gaucher disease type 1 and 3.
    Anurathapan U; Tim-Aroon T; Zhang W; Sanpote W; Wongrungsri S; Khunin N; Chutipongtanate S; Chirdkiatgumchai V; Ngiwsara L; Jaovisidha S; Khongkraparn A; Pakakasama S; Svasti J; Setchell KDR; Wattanasirichaigoon D; Hongeng S
    Pediatr Blood Cancer; 2023 Mar; 70(3):e30149. PubMed ID: 36562549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic enzyme delivery by blood-brain barrier-penetrating SapC-DOPS nanovesicles for treatment of neuronopathic Gaucher disease.
    Sun Y; Liou B; Chu Z; Fannin V; Blackwood R; Peng Y; Grabowski GA; Davis HW; Qi X
    EBioMedicine; 2020 May; 55():102735. PubMed ID: 32279952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of plasma chitotriosidase to assess non-neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy.
    van Dussen L; Hendriks EJ; Groener JE; Boot RG; Hollak CE; Aerts JM
    J Inherit Metab Dis; 2014 Nov; 37(6):991-1001. PubMed ID: 24831585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of Gaucher disease: enzyme replacement therapy.
    Zimran A; Elstein D
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():82-7. PubMed ID: 25345089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL; Zhang YH; Zang Y; Shi HP; Zhang WM; Hu YM
    Zhonghua Er Ke Za Zhi; 2006 Sep; 44(9):653-6. PubMed ID: 17217655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term hematological, visceral, and growth outcomes in children with Gaucher disease type 3 treated with imiglucerase in the International Collaborative Gaucher Group Gaucher Registry.
    El-Beshlawy A; Tylki-Szymanska A; Vellodi A; Belmatoug N; Grabowski GA; Kolodny EH; Batista JL; Cox GF; Mistry PK
    Mol Genet Metab; 2017; 120(1-2):47-56. PubMed ID: 28040394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic stem cell transplantation for Gaucher disease.
    Somaraju UR; Tadepalli K
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD006974. PubMed ID: 29044482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model of neuronopathic Gaucher disease.
    Campbell PE; Harris CM; Harris CM; Sirimanna T; Vellodi A
    J Inherit Metab Dis; 2003; 26(7):629-39. PubMed ID: 14707511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venglustat combined with imiglucerase for neurological disease in adults with Gaucher disease type 3: the LEAP trial.
    Schiffmann R; Cox TM; Dedieu JF; Gaemers SJM; Hennermann JB; Ida H; Mengel E; Minini P; Mistry P; Musholt PB; Scott D; Sharma J; Peterschmitt MJ
    Brain; 2023 Feb; 146(2):461-474. PubMed ID: 36256599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological treatment of pediatric Gaucher disease.
    Gupta P; Pastores G
    Expert Rev Clin Pharmacol; 2018 Dec; 11(12):1183-1194. PubMed ID: 30444430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrinological and metabolic profile of Gaucher disease patients treated with enzyme replacement therapy.
    Kilic A; Emecen Sanli M; Ozsaydı Aktasoglu E; Gokalp S; Biberoğlu G; Inci A; Okur I; Suheyl Ezgu F; Tumer L
    J Pediatr Endocrinol Metab; 2024 May; 37(5):413-418. PubMed ID: 38624096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of type 3 Gaucher disease: unique neurological manifestations and advances in treatment.
    Zhong W; Li D; Fei Y; Hong P
    Acta Neurol Belg; 2024 Aug; 124(4):1213-1223. PubMed ID: 38413480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late-onset Myoclonic Seizure in a 78-year-old Woman with Gaucher Disease.
    Yamaguchi-Takegami N; Takahashi A; Mitsui J; Sugiyama Y; Chikada A; Porto KJL; Takegami N; Sakuishi K; Ishiura H; Yamada K; Shimizu J; Tsuji S; Toda T
    Intern Med; 2024 Mar; 63(6):861-865. PubMed ID: 37558486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant macrophage targeted enzyme replacement therapy for Gaucher disease in India.
    Nagral A; Mewawalla P; Jagadeesh S; Kabra M; Phadke SR; Verma IC; Puri RD; Gupta N; Kishnani PS; Mistry PK
    Indian Pediatr; 2011 Oct; 48(10):779-84. PubMed ID: 22080680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.